Recombinant Phospholipase D from Loxosceles gaucho Binds to Platelets and Promotes Phosphatidylserine Exposure

Autor(es)

Fukuda, Daniel A. ; Caporrino, Maria C. ; Barbaro, Katia C. ; Della-Casa, Maisa S. ; Faquim-Mauro, Eliana L. ; Magalhaes, Geraldo S.

• Tipo de documento: Artigo Científico
• Fonte: TOXINS; v. 9, n. 6 JUN 2017.
• Citações Web of Science: 2

Resumo

Spider envenomation, from the genus Loxosceles, is frequently reported as a cause of necrotic lesions in humans around the world. Among the many components found in the venom of Loxosceles genus, phospholipases D (PLDs) are the most investigated, since they can cause a massive inflammatory response, dermonecrosis, hemolysis and platelet aggregation, among other effects. Even though the PLDs induce strong platelet aggregation, there are no studies showing how the PLDs interact with platelets to promote this effect. Since many agonists must interact with specific receptors on the platelet membrane to induce aggregation, it is reasonable to expect that the PLDs may, in some way, also interact with platelets, to induce this activity. Therefore, to address this possibility, in this work, a recombinant PLD, called LgRec1, from L. gaucho was fused to enhanced green fluorescent protein (EGFP) and used as a probe to detect the interaction of LgRec1 to platelets, by fluorescence-activated cell sorter (FACS) and confocal microscopy. The preservation of biological activities of this chimera toxin was also analyzed. As a first, the results show that LgRec1 does not require plasma components to bind to platelets, although these components are necessary to LgRec1 to induce platelet aggregation. Also, the attachment of LgRec1 to human platelets' cell membranes suggests that the exposure of phosphatidylserine (PS) may act as a scaffold for coagulation factors. Therefore, the results add new information about the binding of Loxosceles PLDs to platelets, which may help unravel how these toxins promote platelet aggregation. (AU)

• Processo FAPESP: 14/23457-9 - Obtenção de imunógeno híbrido recombinante para produção de anticorpos neutralizantes contra o veneno loxoscélico
• Beneficiário: Geraldo Santana Magalhães
• Modalidade de apoio: Auxílio à Pesquisa - Regular